NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

HEMOGENYX PHARMACEUTICALS PLC Logo
Develops cell-based therapies for blood, autoimmune diseases, and viral infections.
United Kingdom
HEMO
HEM Pharma Inc. Logo
Develops microbiome-based healthcare solutions, products, and CDMO services.
South Korea
376270
Hemp Health Spolka Akcyjna Logo
Manages a supply chain for medical marijuana, from cultivation to distribution.
Poland
HMP
Hengrui Pharma Logo
Global pharmaceutical firm focused on R&D for oncology and surgical applications.
China
600276
HERON THERAPEUTICS, INC. /DE/ Logo
Commercial-stage biotech developing therapies for acute care and oncology.
United States of America
HRTX
Develops and manufactures sterile, carbapenem-based antibiotic raw materials.
South Korea
106190
HIKMA Pharmaceuticals PLC Logo
Develops and manufactures generic, branded, and specialty pharmaceutical products.
United Kingdom
HIK
HISAMITSU PHARMACEUTICAL CO.,INC. Logo
A pharmaceutical firm specializing in external pain relief medications.
Japan
4530
HK inno.N Corporation Logo
A biohealth company developing pharmaceuticals and consumer healthcare products.
South Korea
195940
HLB Genex, Inc. Logo
Develops and produces customized enzyme and microbiome-based solutions.
South Korea
187420

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.